[
  {
    "ts": null,
    "headline": "Dividend Champion, Contender, And Challenger Highlights: Week Of October 26",
    "summary": "Get the latest weekly summary on Dividend Champions, Contenders & Challengers. Track dividend changes, upcoming ex-dividend and pay dates.",
    "url": "https://finnhub.io/api/news?id=7fc308958146b9ec4bb25f8abfe9a4f65825f910f23ecfd76eea75fbef836524",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761328391,
      "headline": "Dividend Champion, Contender, And Challenger Highlights: Week Of October 26",
      "id": 137203722,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "Get the latest weekly summary on Dividend Champions, Contenders & Challengers. Track dividend changes, upcoming ex-dividend and pay dates.",
      "url": "https://finnhub.io/api/news?id=7fc308958146b9ec4bb25f8abfe9a4f65825f910f23ecfd76eea75fbef836524"
    }
  },
  {
    "ts": null,
    "headline": "PFE versus BMY: Which Large Oncology Drugmaker Is a Better Pick Now?",
    "summary": "Bristol Myers edges past Pfizer as the stronger oncology pick, backed by new drug launches, acquisitions and pipeline strength",
    "url": "https://finnhub.io/api/news?id=daf3a6aae1e2b200b1008e7195bb28c4df1f3015d149ee5dc3c74f4a45801889",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761319800,
      "headline": "PFE versus BMY: Which Large Oncology Drugmaker Is a Better Pick Now?",
      "id": 137216547,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Bristol Myers edges past Pfizer as the stronger oncology pick, backed by new drug launches, acquisitions and pipeline strength",
      "url": "https://finnhub.io/api/news?id=daf3a6aae1e2b200b1008e7195bb28c4df1f3015d149ee5dc3c74f4a45801889"
    }
  },
  {
    "ts": null,
    "headline": "What To Expect From Gilead In Q3 2025",
    "summary": "Gilead Sciences approaches Q3 2025 results on October 30, hitting new highs and presenting Livdelzi data at The Liver Meeting. Check out why GILD stock is a strong buy.",
    "url": "https://finnhub.io/api/news?id=b5f5ee55f87366db308381563df757bde2335123cbe5c6ab532f82054c10ff85",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761303403,
      "headline": "What To Expect From Gilead In Q3 2025",
      "id": 137202475,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/728909377/image_728909377.jpg?io=getty-c-w1536",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "Gilead Sciences approaches Q3 2025 results on October 30, hitting new highs and presenting Livdelzi data at The Liver Meeting. Check out why GILD stock is a strong buy.",
      "url": "https://finnhub.io/api/news?id=b5f5ee55f87366db308381563df757bde2335123cbe5c6ab532f82054c10ff85"
    }
  },
  {
    "ts": null,
    "headline": "Buy 9 Barron's Better Bets (Than T-Bills) From 15 'Safer' Of 23 October Dividend Dogs",
    "summary": "Discover 9 top high-yield dividend stocks with attractive prices and strong growth forecasts.",
    "url": "https://finnhub.io/api/news?id=8c1303e07f4fc864c75cdba24cdfab801237daac14696e3a104a86411eda40de",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761292480,
      "headline": "Buy 9 Barron's Better Bets (Than T-Bills) From 15 'Safer' Of 23 October Dividend Dogs",
      "id": 137201845,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1354829469/image_1354829469.jpg?io=getty-c-w1536",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "Discover 9 top high-yield dividend stocks with attractive prices and strong growth forecasts.",
      "url": "https://finnhub.io/api/news?id=8c1303e07f4fc864c75cdba24cdfab801237daac14696e3a104a86411eda40de"
    }
  }
]